RE: Notice of Milestone Date and Letter of Conversion To whom it may concern:CSR Agreement • May 9th, 2007
Reference is hereby made to the SUPPRELIN-LA contingent stock rights agreement (“CSR Agreement”) dated April 17, 2007 by and between Indevus Pharmaceuticals, Inc. (“Indevus”) and American Stock Transfer & Trust Company (“AST”). The CSR Agreement was entered into in connection with the merger of Indevus and Valera Pharmaceuticals, Inc. (along with two other contingent stock rights agreements which continue to remain in effect). Our records indicate that you were a participant and held a position in Valera’s common stock as of the close of business on April 17, 2007.
EDF – CSR Agreement – 12 December 2006 1CSR Agreement • December 18th, 2006
. Art. 10: Vigilance with regard to our subcontractors' practices in the area of legal compliance, health and safety, ethical behaviour with customers
